- Home
- STUB vs LKFT Comparison
STUB vs LKFT Comparison
Compare STUB & LKFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$5.87
HOLD
Current Price
$31.70
Company Overview
Basic Information| Metric | STUB | LKFT |
|---|---|---|
| Founded | 2000 | 1999 |
| Country | United States | Belgium |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.0B |
| IPO Year | 2025 | 2007 |
Fundamental Metrics
Financial Performance| Metric | STUB | LKFT |
|---|---|---|
| Price | $5.87 | $31.70 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 14 | 6 |
| Target Price | $10.54 | ★ $30.21 |
| AVG Volume (30 Days) | ★ 4.5M | 256.8K |
| Earning Date | 11-10-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.06 | N/A |
| Revenue | ★ $1,745,188,000.00 | N/A |
| Revenue This Year | $15.84 | N/A |
| Revenue Next Year | $9.82 | N/A |
| P/E Ratio | $101.50 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.22 | $25.68 |
| 52 Week High | $20.54 | $32.41 |
Technical Indicators
Market Signals| Indicator | STUB | LKFT |
|---|---|---|
| Relative Strength Index (RSI) | 47.68 | 66.24 |
| Support Level | $5.65 | $28.50 |
| Resistance Level | $6.38 | $32.41 |
| Average True Range (ATR) | 0.27 | 0.76 |
| MACD | 0.07 | 0.17 |
| Stochastic Oscillator | 40.51 | 96.66 |
Price Performance
Historical Comparison STUB
LKFT
About STUB StubHub Holdings Inc.
Stubhub Holdings Inc operates a ticketing marketplace for live events where fans can buy tickets from sellers of all types through its StubHub and viagogo websites and mobile applications. The company generates majority of its revenue from United States.
About LKFT Lakefront Biotherapeutics American Depositary Shares
Lakefront Biotherapeutics NV a biopharmaceutical company committed to improving the lives of people with severe diseases. It focuses on delivering medicines with transformational impact for patients by accelerating life-changing science and innovation in areas of high unmet need. Its pipelines includes GLPG3667, GLPG5101, and GLPG5301.